Medtronic (MDT) Granted FDA Approval for Endurant II/IIs Stent Graft System

Go back to Medtronic (MDT) Granted FDA Approval for Endurant II/IIs Stent Graft System

Medtronic, Inc. (MDT) PT Lowered to $89 at BMO Capital; 'Updating Model for Hurricane Maria... $250M Impact to Manufacturing in PR'

October 10, 2017 10:07 AM EDT

BMO Capital lowered its price target on Medtronic, Inc. (NYSE: MDT) to $89.00 (from $92.00) while maintaining a Outperform rating, following a model update due to impact of Hurricane Maria.

Analyst Joanne Wuensch notes a cautious outlook following a model update with management citing a $250... More

Medtronic, Inc. (MDT) PT Lowered to $94 at Needham & Company; 'Lowering Estimates for Hurricane Maria Manufacturing Impact'

October 10, 2017 7:59 AM EDT

Needham & Company lowered its price target on Medtronic, Inc. (NYSE: MDT) to $94.00 (from $95.00) while maintaining a Buy rating, following an update on the impact of Hurricane Maria.

Analyst Mike Matson notes a cautious outlook, as the company reported damage caused by Hurricane Maria... More

Medtronic, Inc. (MDT) PT Lowered to $83 at Stifel on Hurricane Maria Update; 'Four Major Manufacturing Facilities Sustained Some Damage'

October 9, 2017 7:47 AM EDT

Stifel lowered its price target on Medtronic, Inc. (NYSE: MDT) to $83.00 (from $91.00) while maintaining a Hold rating, following the company's update on Hurricane Maria in Puerto Rico.

Analyst Rick Wise notes a cautious outlook following the company's update on Hurricane Maria in Puerto... More

Wall Street recedes from highs as quarterly reports loom

October 9, 2017 7:32 AM EDT

By Noel Randewich

(Reuters) - Wall Street fell from record levels on Monday as gains in Microsoft and other technology stocks failed to offset a drop in General Electric and a slide in healthcare stocks.

The S&P healthcare index moved 0.67 percent lower, weighed by a 3.61-percent slide in Medtronic (NYSE: MDT) after the medical device maker warned that its quarterly profit would be impacted after Hurricane Maria hit its operations in Puerto Rico.

The S&P 500 has rallied 14 percent in 2017 and last week hit record highs, buoyed by strong... More

Medtronic, Inc. (MDT) PT Lowered to $85 at Leerink Partners; Hurricane Maria a Significant Headwind

October 9, 2017 7:08 AM EDT

Leerink Partners lowered its price target on Medtronic, Inc. (NYSE: MDT) to $85.00 (from $88.00) while maintaining a Market Perform rating.

Analyst Danielle Antalffy said Hurricane Maria is a significant Q218 headwind. The long-term impact is uncertain.

... More

Wells Fargo Downgrades Medtronic, Inc. (MDT) to Market Perform, Guidance Looks Aggressive

October 9, 2017 2:48 AM EDT

Wells Fargo downgraded Medtronic, Inc. (NYSE: MDT) from Outperform to Market Perform with a price target of $83.00 (from $93.00).

Analyst Larry Biegelsen says the product cycle is hitting a lull and sees headwinds from a plethora of competitive challenges in cardiac/vascular... More

J&J/Animas (JNJ) Pump Exit Positive for Medtronic (MDT), Insulet (PODD), and Tandem Diabetes (TNDM) - Cowen

October 5, 2017 12:49 PM EDT

Cowen analyst Doug Schenkel said J&J/Animas (NYSE: JNJ) exit from the pump business is a positive for Medtronic (NYSE: MDT), Insulet (NASDAQ: PODD), and Tandem Diabetes... More

Animas Corp to Close Operations and Exit Insulin Pump Market (JNJ) (MDT)

October 5, 2017 7:08 AM EDT

Animas Corporation, one of the Johnson & Johnson Diabetes Care Companies, today announced that it intends to discontinue the manufacturing and sale of Animas® Vibe® and OneTouch Ping® insulin pumps, close operations and exit the insulin pump business.

Animas has selected Medtronic plc (NYSE: MDT), a world leader in diabetes, as its partner-of-choice to facilitate a seamless transition for patients, caregivers and healthcare providers. Patients using an Animas insulin pump will be offered the option to transfer to a Medtronic pump.

Patient safety and continuity of care is of utmost importance and... More